4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-16-140712
Options or other derivatives
- Director acquired 2,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SAMPAT MAYANK D. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-12-20 | Grant or award : show line 1 in the form Share Option (Right to Buy) | +2,500 | 2,500 | D |
Loading xslF345X03/v455477_4.xml…